#news #biotech Astellas takes $540M impairment charge over Audentes’ gene therapy trial hold

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Astellas takes $540M impairment charge over Audentes’ gene therapy trial hold .Astellas takes $540M impairment charge over Audentes’ gene therapy trial hold
badams
Tue, 04/27/2021 – 04:19

from FierceBiotech: Biotech https://ift.tt/3u0aQsO